Filed: 8/14/2025ACC: 0001940272-25-000005
📋 What this filing means
ADAR1 CAPITAL MANAGEMENT, LLC filed this quarterly 13F‑HR report disclosing 203 equity positions with a total reported market value of $652.09M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
203
Positions
$652.09M
Total AUM (reported)
72.58M
Total Shares
Allocation by class
COM$338.41M51.9%
COM NEW$55.12M8.5%
SHS$45.25M6.9%
TR UNIT$39.04M6.0%
ALPHA ARCH 1-3$37.99M5.8%
SPONSORED ADS$36.19M5.6%
ADR$29.74M4.6%
Portfolio Concentration
Top 3$163.38M25.1%
4–10$166.42M25.5%
11–25$130.01M19.9%
Rest$192.27M29.5%
Top 3 weight
25.1%
Top 10 weight
50.6%
Voting Authority Distribution
Total shares with voting rights: 71.51M
Sole
Full voting authority
71.51M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole203
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings203
Rows:
KEROS THERAPEUTICS INC
SOLEShares5.39M
TypeSH
Market value$71.95M
11.03%
Sole
5.39M
Shared
0.00
None
0.00
PROTAGONIST THERAPEUTICS INC
SOLEShares948.07K
TypeSH
Market value$52.40M
8.04%
Sole
948.07K
Shared
0.00
None
0.00
SPDR S&P 500 ETF TR
SOLEShares63.18K
TypeSH
Market value$39.04M
5.99%
Sole
63.18K
Shared
0.00
None
0.00
EA SERIES TRUST
SOLEShares337.13K
TypeSH
Market value$37.99M
5.83%
Sole
337.13K
Shared
0.00
None
0.00
ZAI LAB LTD
SOLEShares850.44K
TypeSH
Market value$29.74M
4.56%
Sole
850.44K
Shared
0.00
None
0.00
ABIVAX SA
SOLEShares3.07M
TypeSH
Market value$23.50M
3.60%
Sole
3.07M
Shared
0.00
None
0.00
ROIVANT SCIENCES LTD
SOLEShares1.94M
TypeSH
Market value$21.87M
3.35%
Sole
1.94M
Shared
0.00
None
0.00
PROTHENA CORP PLC
SOLEShares3.38M
TypeSH
Market value$20.49M
3.14%
Sole
3.38M
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares582.15K
TypeSH
Market value$19.23M
2.95%
Sole
582.15K
Shared
0.00
None
0.00
CG ONCOLOGY INC
SOLEShares523.22K
TypeSH
Market value$13.60M
2.09%
Sole
523.22K
Shared
0.00
None
0.00
SPDR SERIES TRUST
SOLEShares135.59K
TypeSH
Market value$12.44M
1.91%
Sole
135.59K
Shared
0.00
None
0.00
BRIDGEBIO PHARMA INC
SOLEShares259.66K
TypeSH
Market value$11.21M
1.72%
Sole
259.66K
Shared
0.00
None
0.00
INHIBIKASE THERAPEUTICS INC
SOLEShares5.12M
TypeSH
Market value$9.99M
1.53%
Sole
5.12M
Shared
0.00
None
0.00
SEPTERNA INC
SOLEShares847.23K
TypeSH
Market value$8.96M
1.37%
Sole
847.23K
Shared
0.00
None
0.00
ARBUTUS BIOPHARMA CORP
SOLEShares2.83M
TypeSH
Market value$8.73M
1.34%
Sole
2.83M
Shared
0.00
None
0.00
89BIO INC
SOLEShares875.98K
TypeSH
Market value$8.60M
1.32%
Sole
875.98K
Shared
0.00
None
0.00
IMMUNOVANT INC
SOLEShares535.07K
TypeSH
Market value$8.56M
1.31%
Sole
535.07K
Shared
0.00
None
0.00
SAVARA INC
SOLEShares3.60M
TypeSH
Market value$8.21M
1.26%
Sole
3.60M
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares259.50K
TypeSH
Market value$8.12M
1.25%
Sole
259.50K
Shared
0.00
None
0.00
BIOAGE LABS INC
SOLEShares1.94M
TypeSH
Market value$8.00M
1.23%
Sole
1.94M
Shared
0.00
None
0.00
PERCEPTIVE CAP SOLUTIONS COR
SOLEShares750K
TypeSH
Market value$7.96M
1.22%
Sole
750K
Shared
0.00
None
0.00
AMYLYX PHARMACEUTICALS INC
SOLEShares1.21M
TypeSH
Market value$7.72M
1.18%
Sole
1.21M
Shared
0.00
None
0.00
JANUX THERAPEUTICS INC
SOLEShares326.99K
TypeSH
Market value$7.55M
1.16%
Sole
62.09K
Shared
0.00
None
0.00
CYTOMX THERAPEUTICS INC
SOLEShares3.08M
TypeSH
Market value$6.99M
1.07%
Sole
3.08M
Shared
0.00
None
0.00
TAYSHA GENE THERAPIES INC
SOLEShares3.01M
TypeSH
Market value$6.95M
1.07%
Sole
3.01M
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
KEROS THERAPEUTICS INCSOLE | COM | 5.39M | SH | $71.95M 11.03% | 5.39M | 0.00 | 0.00 |
PROTAGONIST THERAPEUTICS INCSOLE | COM | 948.07K | SH | $52.40M 8.04% | 948.07K | 0.00 | 0.00 |
SPDR S&P 500 ETF TRSOLE | TR UNIT | 63.18K | SH | $39.04M 5.99% | 63.18K | 0.00 | 0.00 |
EA SERIES TRUSTSOLE | ALPHA ARCH 1-3 | 337.13K | SH | $37.99M 5.83% | 337.13K | 0.00 | 0.00 |
ZAI LAB LTDSOLE | ADR | 850.44K | SH | $29.74M 4.56% | 850.44K | 0.00 | 0.00 |
ABIVAX SASOLE | SPONSORED ADS | 3.07M | SH | $23.50M 3.60% | 3.07M | 0.00 | 0.00 |
ROIVANT SCIENCES LTDSOLE | SHS | 1.94M | SH | $21.87M 3.35% | 1.94M | 0.00 | 0.00 |
PROTHENA CORP PLCSOLE | SHS | 3.38M | SH | $20.49M 3.14% | 3.38M | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 582.15K | SH | $19.23M 2.95% | 582.15K | 0.00 | 0.00 |
CG ONCOLOGY INCSOLE | COM | 523.22K | SH | $13.60M 2.09% | 523.22K | 0.00 | 0.00 |
SPDR SERIES TRUSTSOLE | BLOOMBERG 1-3 MO | 135.59K | SH | $12.44M 1.91% | 135.59K | 0.00 | 0.00 |
BRIDGEBIO PHARMA INCSOLE | COM | 259.66K | SH | $11.21M 1.72% | 259.66K | 0.00 | 0.00 |
INHIBIKASE THERAPEUTICS INCSOLE | COM NEW | 5.12M | SH | $9.99M 1.53% | 5.12M | 0.00 | 0.00 |
SEPTERNA INCSOLE | COM | 847.23K | SH | $8.96M 1.37% | 847.23K | 0.00 | 0.00 |
ARBUTUS BIOPHARMA CORPSOLE | COM | 2.83M | SH | $8.73M 1.34% | 2.83M | 0.00 | 0.00 |
89BIO INCSOLE | COM | 875.98K | SH | $8.60M 1.32% | 875.98K | 0.00 | 0.00 |
IMMUNOVANT INCSOLE | COM | 535.07K | SH | $8.56M 1.31% | 535.07K | 0.00 | 0.00 |
SAVARA INCSOLE | COM | 3.60M | SH | $8.21M 1.26% | 3.60M | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 259.50K | SH | $8.12M 1.25% | 259.50K | 0.00 | 0.00 |
BIOAGE LABS INCSOLE | COM | 1.94M | SH | $8.00M 1.23% | 1.94M | 0.00 | 0.00 |
PERCEPTIVE CAP SOLUTIONS CORSOLE | CL A ORD SHS | 750K | SH | $7.96M 1.22% | 750K | 0.00 | 0.00 |
AMYLYX PHARMACEUTICALS INCSOLE | COM | 1.21M | SH | $7.72M 1.18% | 1.21M | 0.00 | 0.00 |
JANUX THERAPEUTICS INCSOLE | COM | 326.99K | SH | $7.55M 1.16% | 62.09K | 0.00 | 0.00 |
CYTOMX THERAPEUTICS INCSOLE | COM | 3.08M | SH | $6.99M 1.07% | 3.08M | 0.00 | 0.00 |
TAYSHA GENE THERAPIES INCSOLE | COM SHS | 3.01M | SH | $6.95M 1.07% | 3.01M | 0.00 | 0.00 |
Page 1 of 9
…